SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-110334
Filing Date
2015-03-30
Accepted
2015-03-30 07:33:52
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d856407d10k.htm 10-K 564852
2 EX-23.1 d856407dex231.htm EX-23.1 1458
3 EX-31.1 d856407dex311.htm EX-31.1 8551
4 EX-32.1 d856407dex321.htm EX-32.1 3411
11 GRAPHIC g856407g02h08.jpg GRAPHIC 136696
  Complete submission text file 0001193125-15-110334.txt   4706023

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rxii-20141231.xml EX-101.INS 473627
6 XBRL TAXONOMY EXTENSION SCHEMA rxii-20141231.xsd EX-101.SCH 34764
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxii-20141231_cal.xml EX-101.CAL 63995
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxii-20141231_def.xml EX-101.DEF 152516
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxii-20141231_lab.xml EX-101.LAB 356733
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxii-20141231_pre.xml EX-101.PRE 271954
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36304 | Film No.: 15732469
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences